Literature DB >> 301988

Immunotherapy of cancer.

H F Oettgen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 301988     DOI: 10.1056/NEJM197709012970907

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  Logistics of tumor immunology.

Authors:  H Kirchner
Journal:  Klin Wochenschr       Date:  1982-01-04

2.  Lymphoproliferative response as an index of cellular immunity in malignant melanoma of the uvea and its correlation with the histological features of the tumour.

Authors:  M S Sunba; A H Rahi; G Morgan; E J Holborow
Journal:  Br J Ophthalmol       Date:  1980-08       Impact factor: 4.638

3.  Cell-mediated immune responses between HLA-identical siblings: recognition of antigenic changes associated with acute myelogenous leukaemia.

Authors:  K S Zier; C Huber; E Albert; H Braunsteiner
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

4.  Tumor immunity. An overview.

Authors:  B V Siegel
Journal:  Am J Pathol       Date:  1978-11       Impact factor: 4.307

5.  Influence of C. parvum on the effectiveness of passive serotherapy in the control of the EL4 lymphoma in C57BL/6 mice.

Authors:  G J O'Neill; N Stebbing
Journal:  Br J Cancer       Date:  1980-02       Impact factor: 7.640

Review 6.  Biomaterial-based platforms for in situ dendritic cell programming and their use in antitumor immunotherapy.

Authors:  João Calmeiro; Mylène Carrascal; Célia Gomes; Amílcar Falcão; Maria Teresa Cruz; Bruno Miguel Neves
Journal:  J Immunother Cancer       Date:  2019-09-04       Impact factor: 13.751

7.  COVID-19 vaccine and boosted immunity: Nothing ad interim to do?

Authors:  Luca Roncati; Maria Vadalà; Veronica Corazzari; Beniamino Palmieri
Journal:  Vaccine       Date:  2020-10-09       Impact factor: 3.641

8.  Antibody-dependent cellular cytotoxicity against drug-induced antigens in L5178Y mouse lymphoma.

Authors:  P Franco; F Veronese; F Levi; A Goldin; A Nicolin
Journal:  Br J Cancer       Date:  1982-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.